Omnicell Past Earnings Performance
Past criteria checks 0/6
Omnicell's earnings have been declining at an average annual rate of -46.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 6.4% per year.
Key information
-46.5%
Earnings growth rate
-47.0%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 6.4% |
| Return on equity | -1.4% |
| Net Margin | -1.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Omnicell makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,064 | -18 | 385 | 88 |
| 30 Jun 24 | 1,080 | -21 | 395 | 91 |
| 31 Mar 24 | 1,103 | -21 | 408 | 93 |
| 31 Dec 23 | 1,147 | -20 | 428 | 93 |
| 30 Sep 23 | 1,186 | -34 | 454 | 97 |
| 30 Jun 23 | 1,235 | -23 | 463 | 97 |
| 31 Mar 23 | 1,268 | -18 | 475 | 101 |
| 31 Dec 22 | 1,296 | 6 | 479 | 102 |
| 30 Sep 22 | 1,309 | 48 | 453 | 96 |
| 30 Jun 22 | 1,258 | 61 | 438 | 91 |
| 31 Mar 22 | 1,199 | 72 | 412 | 83 |
| 31 Dec 21 | 1,132 | 78 | 381 | 76 |
| 30 Sep 21 | 1,070 | 80 | 354 | 69 |
| 30 Jun 21 | 987 | 60 | 327 | 65 |
| 31 Mar 21 | 914 | 35 | 306 | 65 |
| 31 Dec 20 | 892 | 32 | 297 | 66 |
| 30 Sep 20 | 891 | 38 | 298 | 70 |
| 30 Jun 20 | 906 | 49 | 298 | 71 |
| 31 Mar 20 | 924 | 69 | 298 | 70 |
| 31 Dec 19 | 897 | 61 | 290 | 69 |
| 30 Sep 19 | 860 | 54 | 274 | 67 |
| 30 Jun 19 | 836 | 48 | 269 | 66 |
| 31 Mar 19 | 807 | 38 | 266 | 64 |
| 31 Dec 18 | 787 | 38 | 259 | 65 |
| 30 Sep 18 | 772 | 54 | 258 | 64 |
| 30 Jun 18 | 754 | 48 | 249 | 64 |
| 31 Mar 18 | 747 | 44 | 245 | 67 |
| 31 Dec 17 | 713 | 31 | 241 | 66 |
| 30 Sep 17 | 688 | -1 | 233 | 65 |
| 30 Jun 17 | 678 | -6 | 238 | 64 |
| 31 Mar 17 | 670 | -9 | 243 | 60 |
| 31 Dec 16 | 696 | 10 | 230 | 58 |
| 30 Sep 16 | 651 | 8 | 231 | 52 |
| 30 Jun 16 | 599 | 14 | 210 | 46 |
| 31 Mar 16 | 539 | 24 | 184 | 41 |
| 31 Dec 15 | 485 | 31 | 165 | 35 |
| 30 Sep 15 | 476 | 32 | 166 | 34 |
| 30 Jun 15 | 463 | 32 | 164 | 32 |
| 31 Mar 15 | 455 | 31 | 161 | 30 |
| 31 Dec 14 | 441 | 31 | 156 | 28 |
| 30 Sep 14 | 425 | 28 | 149 | 27 |
| 30 Jun 14 | 407 | 29 | 145 | 26 |
| 31 Mar 14 | 395 | 27 | 141 | 27 |
| 31 Dec 13 | 381 | 24 | 139 | 27 |
Quality Earnings: OC9 is currently unprofitable.
Growing Profit Margin: OC9 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OC9 is unprofitable, and losses have increased over the past 5 years at a rate of 46.5% per year.
Accelerating Growth: Unable to compare OC9's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OC9 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: OC9 has a negative Return on Equity (-1.44%), as it is currently unprofitable.